<img src="https://i-invdn-com.investing.com/news/World_News_9_M_1440052127.jpg" /><br>BofA Securities initiates new coverage of Immunovant Buy with a price target of $26.00 <br><a href="https://www.investing.com/news/pro/immunovant-inc-receives-investment-bank-analyst-rating-update-3068847">Source link </a>